Recently, the Obama administration announced the launch of a “moonshot” approach, led by vice president Biden, to finding a cure for cancer and reducing cancer mortality in the United States. Although preliminary communications about the plan mention the development of new vaccines to prevent cancer, the moonshot approach has generally been framed as a search for a cure for cancer, with increased investment in promising therapeutic approaches such as immunotherapy and the creation and sharing of data to simplify the search for personalized medicine and genomic markers that would permit customized therapies.1